<code id='0F94B04495'></code><style id='0F94B04495'></style>
    • <acronym id='0F94B04495'></acronym>
      <center id='0F94B04495'><center id='0F94B04495'><tfoot id='0F94B04495'></tfoot></center><abbr id='0F94B04495'><dir id='0F94B04495'><tfoot id='0F94B04495'></tfoot><noframes id='0F94B04495'>

    • <optgroup id='0F94B04495'><strike id='0F94B04495'><sup id='0F94B04495'></sup></strike><code id='0F94B04495'></code></optgroup>
        1. <b id='0F94B04495'><label id='0F94B04495'><select id='0F94B04495'><dt id='0F94B04495'><span id='0F94B04495'></span></dt></select></label></b><u id='0F94B04495'></u>
          <i id='0F94B04495'><strike id='0F94B04495'><tt id='0F94B04495'><pre id='0F94B04495'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:7272
          CommonSpirit, one of the country’s biggest health systems, keeps growing its hospital count and debt, even as it loses money. Adobe

          CommonSpirit Health keeps adding more hospitals — and billions in new debt — even as it bleeds money.

          Formed through a 2019 merger and headquartered in Chicago, CommonSpirit is one of the country’s largest not-for-profit health systems, with north of 140 hospitals. Even though it has scale, the system has lost money almost every year since its inception, including $2.7 billion on operations in the past two years. CommonSpirit’s latest financial statement also shows its total debt grew $2.9 billion in the year that ended June 30.

          advertisement

          “They are not doing well, despite this mega-merger, but they’re doubling down,” said Ge Bai, an accounting and health policy professor at Johns Hopkins University. “They keep trying to merge.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Three issues to watch in global health in 2024
          Three issues to watch in global health in 2024

          ChristineKao/STATAsweenterthefifthyearofthischallengingdecade,lifefinallyappearstobeinchingtowardnor

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Biotech reporter’s notebook: A sunnier mood at JPM 2024

          AlexHogan/STATSANFRANCISCO—Itseemedliketherewasapointduringlastyear’sJ.P.MorganHealthcareConferencew